OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection
Sun Hong Yoo, Ji Yoon Kim, Young‐Suk Lim, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 939-946
Closed Access | Times Cited: 34
Sun Hong Yoo, Ji Yoon Kim, Young‐Suk Lim, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 939-946
Closed Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis
Shaowen Jiang, Simin Guo, Yan Huang, et al.
Hepatology International (2024) Vol. 18, Iss. 3, pp. 892-903
Open Access | Times Cited: 11
Shaowen Jiang, Simin Guo, Yan Huang, et al.
Hepatology International (2024) Vol. 18, Iss. 3, pp. 892-903
Open Access | Times Cited: 11
Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy
Sha She, Jinzhi Shi, Jiling Zhu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 9
Sha She, Jinzhi Shi, Jiling Zhu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 9
Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis
Wen‐Juei Jeng, Rong‐Nan Chien, Yi‐Cheng Chen, et al.
Hepatology (2023) Vol. 79, Iss. 3, pp. 690-703
Closed Access | Times Cited: 18
Wen‐Juei Jeng, Rong‐Nan Chien, Yi‐Cheng Chen, et al.
Hepatology (2023) Vol. 79, Iss. 3, pp. 690-703
Closed Access | Times Cited: 18
The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination
Anliang Xia, Qi Yue, Mingming Zhu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Anliang Xia, Qi Yue, Mingming Zhu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
Yizhen Fu, Yaojun Zhang, Dandan Hu, et al.
Journal of Clinical Oncology (2025)
Closed Access
Yizhen Fu, Yaojun Zhang, Dandan Hu, et al.
Journal of Clinical Oncology (2025)
Closed Access
Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma
Bingtao Hao, Yachong Liu, Bohan Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Bingtao Hao, Yachong Liu, Bohan Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
A Novel Nomogram for the Preoperative Prediction of Edmondson-Steiner Grade III-IV in Hepatocellular Carcinoma Patients
Zheyu Zhou, Cao Shuya, Chaobo Chen, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1399-1409
Open Access | Times Cited: 9
Zheyu Zhou, Cao Shuya, Chaobo Chen, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1399-1409
Open Access | Times Cited: 9
HBsAg seroclearance reduces the risk of late recurrence in HBV-related HCC
Bao Jin, Shunda Du, Huayu Yang
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1469-1470
Open Access | Times Cited: 10
Bao Jin, Shunda Du, Huayu Yang
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1469-1470
Open Access | Times Cited: 10
Prediction of late recurrence after curative-intent resection using MRI-measured spleen volume in patients with hepatocellular carcinoma and cirrhosis
Chongtu Yang, Jia Tan, Yidi Chen, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Chongtu Yang, Jia Tan, Yidi Chen, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience
Shenyu Zhang, Guibin Yang, Ruipeng Song, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Shenyu Zhang, Guibin Yang, Ruipeng Song, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients
Weihua Cao, Y Q Zhang, Xinxin Li, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1158-1168
Closed Access | Times Cited: 1
Weihua Cao, Y Q Zhang, Xinxin Li, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1158-1168
Closed Access | Times Cited: 1
Letter: ‘Impact of HCV Eradication on Recurrence Pattern and Long‐Term Outcomes in Patients With HCV ‐Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation’
You‐Jian Xu, Hui‐Ming Pang
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 1
You‐Jian Xu, Hui‐Ming Pang
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 1
Different power modes of microwave ablation for hepatocellular carcinoma: Evaluation of recurrence rate and factors related to recurrence
Tiantian Dong, Fang Nie, Ting Liu, et al.
Asian Journal of Surgery (2023) Vol. 46, Iss. 9, pp. 3520-3528
Open Access | Times Cited: 3
Tiantian Dong, Fang Nie, Ting Liu, et al.
Asian Journal of Surgery (2023) Vol. 46, Iss. 9, pp. 3520-3528
Open Access | Times Cited: 3
HBsAg seroclearance and reduction in late recurrence of HBV-related HCC: Causality or co-existence?
Yong‐Kang Diao, Qing-Yu Kong, Tian Yang
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1468-1469
Closed Access | Times Cited: 3
Yong‐Kang Diao, Qing-Yu Kong, Tian Yang
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1468-1469
Closed Access | Times Cited: 3
Antiviral therapy, HBsAg seroclearance and late recurrence of hepatitis B-related hepatocellular carcinoma
Siyu Liu, Yuan Chen, Xiangmin Tong
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1471-1472
Closed Access | Times Cited: 3
Siyu Liu, Yuan Chen, Xiangmin Tong
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1471-1472
Closed Access | Times Cited: 3
Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
Jonggi Choi
Gut and Liver (2023) Vol. 17, Iss. 2, pp. 179-180
Open Access | Times Cited: 1
Jonggi Choi
Gut and Liver (2023) Vol. 17, Iss. 2, pp. 179-180
Open Access | Times Cited: 1
Viral Status and Treatment Efficacy in Recurrent Hepatocellular Carcinoma After Primary Resection
Hou-Ying Cheng, Rey‐Heng Hu, Chih‐Yang Hsiao, et al.
Journal of Gastrointestinal Surgery (2023) Vol. 27, Iss. 8, pp. 1594-1610
Closed Access | Times Cited: 1
Hou-Ying Cheng, Rey‐Heng Hu, Chih‐Yang Hsiao, et al.
Journal of Gastrointestinal Surgery (2023) Vol. 27, Iss. 8, pp. 1594-1610
Closed Access | Times Cited: 1
Development of a clinical scoring model to predict the overall and relapse‑free survival of patients with hepatocellular carcinoma following a hepatectomy
Wanyu Deng, Fu Chen, Yuanxiang Li, et al.
Molecular and Clinical Oncology (2023) Vol. 19, Iss. 5
Open Access | Times Cited: 1
Wanyu Deng, Fu Chen, Yuanxiang Li, et al.
Molecular and Clinical Oncology (2023) Vol. 19, Iss. 5
Open Access | Times Cited: 1
HBV and HCV Infection Prophylaxis in Liver Transplant Recipients
Mariana Mihăilă, Cristina Mădălina Pascu, Andreea Andrunache, et al.
Infectious diseases (2023)
Open Access | Times Cited: 1
Mariana Mihăilă, Cristina Mădălina Pascu, Andreea Andrunache, et al.
Infectious diseases (2023)
Open Access | Times Cited: 1
Antiviral Strategies in the Treatment of Human and Animal Viral Infections
Arli Aditya Parikesit
Infectious diseases (2023)
Open Access | Times Cited: 1
Arli Aditya Parikesit
Infectious diseases (2023)
Open Access | Times Cited: 1
Letter to the Editor on: “Risk factors, patterns, and outcome predictors of late recurrence in patients with hepatocellular carcinoma after curative resection: A large cohort study with long-term follow-up results”
Shiye Yang, Huoqi Liang, Xing Li, et al.
Surgery (2024) Vol. 176, Iss. 3, pp. 983-984
Closed Access
Shiye Yang, Huoqi Liang, Xing Li, et al.
Surgery (2024) Vol. 176, Iss. 3, pp. 983-984
Closed Access
Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma
Myung Ji Goh, Hee Chul Park, Nalee Kim, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 37
Open Access
Myung Ji Goh, Hee Chul Park, Nalee Kim, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 37
Open Access
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis
Jianxin Peng, Lingzhi Wang, Qiuting Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Jianxin Peng, Lingzhi Wang, Qiuting Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Effect of nucleos(t)ide analogue discontinuation on the prognosis of HBeAg ‐negative hepatitis B virus‐related hepatocellular carcinoma after hepatectomy: A propensity score matching analysis
Ting Sun, Yiwen Qiu, Tao Wang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access
Ting Sun, Yiwen Qiu, Tao Wang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access
Hepatocellular carcinoma in HBsAg seroclearance: clinical features, recurrence, and prognosis following curative hepatectomy
Wei Xu, Huai Gong, Bolun Li, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Wei Xu, Huai Gong, Bolun Li, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
